Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
Recruiting · NCT03955445 · Registry updated 2026-08-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, complement 3 glomerulopathy, glomerulonephritis, immune system disorder, kidney disorder, membranoproliferative glomerulonephritis, nephritis, urinary system disorder | Recruiting | Phase 3 | 2026-08-07 | NCT03955445 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Novartis Pharmaceuticals | 432 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Childrens Hospital Colorado | Aurora | United States | 23 |
| Col Uni Med Center New York Presby | New York | United States | 6 |
| Georgia Nephrology Research Inst | Lawrenceville | United States | 3 |
| University of Iowa Health Care | Iowa City | United States | 3 |
| University of Minnesota | Minneapolis | United States | 325 |